Found: 65
Select item for more details and to access through your institution.
Germline BRCA mutation does not prevent response to taxane-based therapy for the treatment of castration-resistant prostate cancer.
- Published in:
- BJU International, 2012, v. 109, n. 5, p. 713, doi. 10.1111/j.1464-410X.2011.10292.x
- By:
- Publication type:
- Article
Regional lymph node status in patients with bladder cancer found to be pathological stage T0 at radical cystectomy following systemic chemotherapy.
- Published in:
- BJU International, 2011, v. 108, n. 8b, p. E272, doi. 10.1111/j.1464-410X.2010.09981.x
- By:
- Publication type:
- Article
DO MIXED HISTOLOGICAL FEATURES AFFECT SURVIVAL BENEFIT FROM NEOADJUVANT PLATINUM-BASED COMBINATION CHEMOTHERAPY IN PATIENTS WITH LOCALLY ADVANCED BLADDER CANCER?
- Published in:
- BJU International, 2011, v. 108, n. 5, p. 699, doi. 10.1111/j.1464-410X.2010.10006.x
- By:
- Publication type:
- Article
Hypoxia-inducible factor and mammalian target of rapamycin pathway markers in urothelial carcinoma of the bladder: possible therapeutic implications.
- Published in:
- BJU International, 2011, v. 107, n. 5, p. 844, doi. 10.1111/j.1464-410X.2010.09517.x
- By:
- Publication type:
- Article
Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
- Published in:
- BJU International, 2008, v. 102, n. 9 Pt. B, p. 1339, doi. 10.1111/j.1464-410X.2008.07980.x
- By:
- Publication type:
- Article
A Case of Rapidly Progressive De Novo Metastatic Small‐Cell Neuroendocrine Prostate Cancer.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-33980-9
- By:
- Publication type:
- Article
Circulating Tumor Cells: A Potential Bladder Cancer Biomarker?
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 1, p. 105
- By:
- Publication type:
- Article
Dose Intensity in Real-World Patients With Metastatic Renal Cell Carcinoma Taking Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Genitourinary Cancer, 2023, v. 21, n. 3, p. 357, doi. 10.1016/j.clgc.2023.02.007
- By:
- Publication type:
- Article
Testis Cancer Care in North Carolina: Implications for Real-World Evidence and Cancer Surveillance.
- Published in:
- Clinical Genitourinary Cancer, 2022, v. 20, n. 4, p. 307, doi. 10.1016/j.clgc.2022.04.006
- By:
- Publication type:
- Article
Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.
- Published in:
- Clinical Genitourinary Cancer, 2021, v. 19, n. 4, p. 362, doi. 10.1016/j.clgc.2021.03.007
- By:
- Publication type:
- Article
Managing potential adverse events during treatment with enfortumab vedotin + pembrolizumab in patients with advanced urothelial cancer.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1326715
- By:
- Publication type:
- Article
Somatic mutation of fibroblast growth factor receptor-3 ( FGFR3) defines a distinct morphological subtype of high-grade urothelial carcinoma.
- Published in:
- Journal of Pathology, 2011, v. 224, n. 2, p. 270, doi. 10.1002/path.2892
- By:
- Publication type:
- Article
Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept Study.
- Published in:
- Scientific Reports, 2017, p. 43356, doi. 10.1038/srep43356
- By:
- Publication type:
- Article
Advanced Urothelial Carcinoma: Moving the Field Forward.
- Published in:
- Oncology (08909091), 2013, v. 27, n. 3, p. 233
- By:
- Publication type:
- Article
SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer.
- Published in:
- World Journal of Urology, 2019, v. 37, n. 1, p. 95, doi. 10.1007/s00345-018-2486-1
- By:
- Publication type:
- Article
Correction: A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer.
- Published in:
- PLoS ONE, 2021, v. 16, n. 6, p. 1, doi. 10.1371/journal.pone.0253021
- By:
- Publication type:
- Article
Can genitourinary cancer survivors understand quality of life (QoL) questionnaires? Assessing the readability of commonly used urologic oncology QoL instruments.
- Published in:
- International Journal of Urology, 2024, v. 31, n. 9, p. 1061, doi. 10.1111/iju.15501
- By:
- Publication type:
- Article
Bladder cancer.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinoma.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 7, p. 1545, doi. 10.1002/cncr.20541
- By:
- Publication type:
- Article
Phase I trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Phase I trial of interferon α2b and liposome-encapsulated all- trans retinoic acid in the treatment of patients with advanced renal cell carcinoma.
- Published in:
- Cancer (0008543X), 2002, v. 95, n. 6, p. 1220, doi. 10.1002/cncr.10809
- By:
- Publication type:
- Article
Active chemotherapy for collecting duct carcinoma of the kidney: a case report and review of the literature.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Entinostat induces antitumor immune responses through immune editing of tumor neoantigens.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussion.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1427452
- By:
- Publication type:
- Article
Management of invasive bladder cancer in patients who are not candidates for or decline cystectomy.
- Published in:
- Therapeutic Advances in Urology, 2011, v. 3, n. 3, p. 107, doi. 10.1177/1756287211407543
- By:
- Publication type:
- Article
Phase II trial of palbociclib in patients with metastatic urothelial cancer after failure of first-line chemotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Modelling cost‐effectiveness of a biomarker‐based approach to neoadjuvant chemotherapy for muscle‐invasive bladder cancer.
- Published in:
- BJU International, 2018, v. 122, n. 3, p. 434, doi. 10.1111/bju.14220
- By:
- Publication type:
- Article
Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base.
- Published in:
- BJU International, 2014, v. 114, n. 5, p. 719, doi. 10.1111/bju.12601
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy for bladder cancer does not increase risk of perioperative morbidity.
- Published in:
- BJU International, 2014, v. 114, n. 2, p. 221, doi. 10.1111/bju.12585
- By:
- Publication type:
- Article
Association of hospital volume with conditional 90-day mortality after cystectomy: an analysis of the National Cancer Data Base.
- Published in:
- BJU International, 2014, v. 114, n. 1, p. 46, doi. 10.1111/bju.12566
- By:
- Publication type:
- Article
Phase II study of everolimus in metastatic urothelial cancer.
- Published in:
- BJU International, 2013, v. 112, n. 4, p. 462, doi. 10.1111/j.1464-410X.2012.11720.x
- By:
- Publication type:
- Article
Secondary Immune Thrombocytopenia in Metastatic Renal Cell Carcinoma: A Case Report and Discussion of the Literature.
- Published in:
- Case Reports in Oncology, 2020, v. 13, n. 3, p. 1349, doi. 10.1159/000511067
- By:
- Publication type:
- Article
Correction to: Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Fibroblast growth factor receptor 3 alterations and response to immune checkpoint inhibition in metastatic urothelial cancer: a real world experience.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 4, p. 491, doi. 10.1080/0284186X.2017.1369565
- By:
- Publication type:
- Article
Novel Agents in Invasive Urothelial Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2012, v. 10, n. 8, p. 1
- By:
- Publication type:
- Article
Mocetinostat for patients with previously treated, locally advanced/metastatic urothelial carcinoma and inactivating alterations of acetyltransferase genes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Reply to vitamin D status may explain racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.
- Published in:
- 2016
- By:
- Publication type:
- Letter
Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Genomic profiling of advanced bladder cancer to guide the use of targeted therapeutics.
- Published in:
- 2016
- By:
- Publication type:
- commentary
Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 15, p. 2586, doi. 10.1002/cncr.29387
- By:
- Publication type:
- Article
Cytotoxic and DNA-targeted therapy in urothelial cancer: Have we squeezed the lemon enough?
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 2, p. 179, doi. 10.1002/cncr.28754
- By:
- Publication type:
- Article
Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 1, p. 86, doi. 10.1002/cncr.28397
- By:
- Publication type:
- Article
Tools to improve clinical trial design in urothelial cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 16, p. 2950, doi. 10.1002/cncr.28176
- By:
- Publication type:
- Article
Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Clinical Benefits of a Multivariate Prediction Model for Bladder Cancer.
- Published in:
- Cancer (0008543X), 2009, v. 115, n. 23, p. 5460, doi. 10.1002/cncr.24615
- By:
- Publication type:
- Article